A technology-based intervention to reduce alcohol use after metabolic and bariatric surgery: feasibility, acceptability, and preliminary outcomes

Document Type

Article

Publication Date

8-18-2025

Publication Title

Surg Obes Relat Dis

Abstract

BACKGROUND: Patients who undergo metabolic and bariatric surgery (MBS) are at increased risk for an alcohol use disorder. A technology-based intervention, rooted in motivational interviewing, could broadly reach patients after MBS and has the potential to reduce alcohol use.

OBJECTIVE: Examine the feasibility, acceptability, and preliminary outcomes of a technology-based intervention to reduce alcohol use delivered after MBS.

SETTING: Health system.

METHODS: Participants (N = 60) who were 3-18 months post-MBS were randomized to the intervention or treatment-as-usual control group. The tailored intervention consisted of 2 (15-minute) sessions of interactive web-based content followed by 3-months of daily text messaging. Participants completed baseline and a postintervention assessment (91.7% retention).

RESULTS: Participants were primarily female (90%), White (55.0%) or Black (43.3%), with a mean age of 44.6 years (SD = 10.4). Of those randomized to the intervention (n = 24), 83.3% (n = 20) began the intervention and 95% (n = 19) completed it. The majority of participants rated all intervention components positively and 100% agreed that other patients would use the intervention. The intervention group reported a significant increase in level of motivation to avoid alcohol use from baseline to postintervention (P = .02), whereas the control group did not show a significant change (P = .73). At the postintervention, the intervention group had significantly fewer participants endorsing alcohol use than the control group (43.5% versus 75%; X(2) = 5.63, P = .02).

CONCLUSION: A technology-based intervention delivered after MBS was feasible, acceptable, and showed promising preliminary outcomes for increasing motivation to avoid alcohol use as well as reducing alcohol use.

PubMed ID

40885652

ePublication

ePub ahead of print

Share

COinS